Skip to main content
SpringerLink
Log in

Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The effects of nicotinic receptor ligands on performance in a task measuring sustained attention, or vigilance, were tested. This task required the animals to discriminate between signal and non-signal events. The sequence of signal (central panel light illumination for 500, 50 or 25 ms) and non-signal presentations was randomized over three blocks of 54 trials each (27 signal trials, 9 per length, and 27 non-signal trials). A left lever press following a signal was counted as a hit, and a right lever press following a non-signal event was counted as a correct rejection. Hits and correct rejections were rewarded, whereas misses and false alarms (defined as incorrect right and left lever presses, respectively) were not. Baseline performance was characterized by a signal length dependent ability of the animals to discriminate between signal and non-signal events. Administration of nicotine (0.19, 0.62, 1.9 µmol) or of two novel nicotinic receptor agonists, ABT-418 and A-82695, did not produce main effects on vigilance performance. Lobeline (1.9, 6.2, 19 µmol), a nicotinic receptor ligand with mixed agonist/antagonist activities, impaired the animals' ability to discriminate between signal and non-signal events. The antagonist mecamylamine (5, 15, 50 µmol) potently impaired performance while increasing the number of errors of omission. The lack of effect of nicotine largely corresponds with the findings from previous studies on the acute effects of nicotine in intact subjects and nonsmoking humans. While the detrimental effects of lobeline may have been related to the antagonist effects of this compound, the reasons for the differences between the effects of nicotine and lobeline still remain unsettled. These data support the hypothesis that nicotine receptor mechanisms are maximally activated in intact animals performing this task, and suggest that effects of acute nicotinic agonist treatment would not produce further cognitive benefit for these animals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aizenman E, Tang LH, Reynolds IJ (1991) Effects of nicotine agonists on the NMDA receptor. Brain Res 551:355–357

    Google Scholar 

  • Arneric SP, Sullivan JP, Briggs CA, Donelly-Roberts D, Anderson DJ, Raskiewicz JL, Hughes M, Cadman ED, Adams P, Garvey DS, Wasicak J, Williams M (1994) (S)-3-methyl-5-(1-Methyl-2-pyrrolidinyl) isoxazole (ABT-418): a novel cholinergic ligand with cognition enhancing and anxiolytic activity: I. In vitro characterization. J Pharmacol Exp Ther 270:310–318

    Google Scholar 

  • Arneric SP, Sullivan JP, Williams M (1995) Neuronal nicotinic acetylcholine receptors. Novel targets for CNS therapeutics. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York. (in press)

    Google Scholar 

  • Bättig K (1981) Smoking and the behavioral effects of nicotine. Trends Pharmacol Sci 2:145–147

    Google Scholar 

  • Brioni JD, Arneric SP (1993) Nicotinic receptor agonists facilitate retention of avoidance training: participation of dopaminergic mechanisms. Behav Neural Biol 59:57–62

    Google Scholar 

  • Craig A (1987) Signal detection theory and probability matching apply to vigilance. Hum Fact 29:645–652

    Google Scholar 

  • Decker MW, Majchrzak MJ (1992) Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats. Psychopharmacology 107:530–534

    Google Scholar 

  • Decker MW, Majchrzak MJ (1993) Effects of central nicotinic cholinergic receptor blockade produced by chlorisondamine on learning and memory performance in rats. Behav Neural Biol 60:163–171

    Google Scholar 

  • Decker MW, Majchrzak MJ, Anderson DJ (1992) Effects of nicotine on spatial memory deficits in rats with septal lesions. Brain Res 572:281–285

    Google Scholar 

  • Decker MW, Majchrzak MJ, Arneric SP (1993) Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol Biochem Behav 45:571–576

    Google Scholar 

  • Decker MW, Brioni JD, Sullivan JP, Buckley MJ, Radek RJ, Raszkiewicz JL, Kang CH, Kim DJB, Giardina WJ, Wasicak J, Garvey DS, Williams M, Arneric SP (1994) (S)-3-Methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT-418): a novel cholinergic ligand with cognition enhancing and anxiolytic activities: II. In vivo characterization. J Pharmacol Exp Ther 270:319–328

    Google Scholar 

  • De Sarno P, Giacobini E (1989) Modulation of acetylcholine release by nicotinic receptors in the rat brain. J Neurosci Res 22:194–200

    Google Scholar 

  • Dudchenko P, Gordon BM, Sarter M (1994) Effects of benzodiazepine receptor ligands on simultaneous discriminations of variable difficulty. J Psychopharmacol 8:141–147

    Google Scholar 

  • Dunne MP, MacDonald D, Hartley LR (1986) The effects of nicotine upon memory and problem solving performance. Physiol Behav 37:849–854

    Google Scholar 

  • Dunnett SB, Martel FL (1990) Proactive interference effects on short-term memory in rats: 1. Basic parameters and drug effects. Behav Neurosci 104:655–665

    Google Scholar 

  • Elrod K, Buccafusco JJ, Jackson WJ (1988) Nicotine enhances delayed matching-to-sample performance by primates. Life Sci 43:277–287

    Google Scholar 

  • Frey PW, Colliver JA (1973) Sensitivity and responsivity measures for discrimination learning. Learn Motiv 4:327–342

    Google Scholar 

  • Garvey DS, Wasicak J, Decker MW, Brioni JD, Buckley MJ, Sullivan JP, Carrera GM, Holladay MH, Arneric SP, Williams M (1994) Novel isoxazoles which interact with brain cholinergic channel receptors that have intrinsic cognitive enhancing and anxiolytic activities. J Med Chem 37:1055–1059

    Google Scholar 

  • Geller I, Hartmann R, Blum K (1971) Effects of nicotine, nicotine monomethiodide, lobeline, chlordiazepoxide, meprobamate and caffeine on a discrimination task in laboratory rats. Psychopharmacology 20:355–365

    Google Scholar 

  • Gray JA, Mitchell SN, Joseph MH, Grigoryan GA, Dawe S, Hodges H (1994) Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine. Drug Dev Res 31:3–17

    Google Scholar 

  • Haroutunian V, Barnes E, Davis KL (1985) Cholinergic modulation of memory in rats. Psychopharmacology 87:266–271

    Google Scholar 

  • Hodges H, Gray JA, Allen Y, Sinden J (1991) The role of forebrain cholinergic projection system in performance in the radial-arm maze in memory-impaired rats. In: Adlkofer F, Thurau K (eds) Effects of nicotine on biological systems. Birkhäuser, Basel, pp 389–399

    Google Scholar 

  • Holley LA, Wiley RG, Lappi DA, Sarter M (1994) Cortical cholinergic deafferentation following the intracortical infusion of 192 IgG-saporin: a quantitative histochemical study. Brain Res 663:277–286

    Google Scholar 

  • Jones GMM, Sahakian BJ, Warburton DM, Gray JA (1992) Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology 108:485–494

    Google Scholar 

  • Koelega HS (1993) Stimulant drugs and vigilance performance: a review. Psychopharmacology 111:1–16

    Google Scholar 

  • Koelega HA, Brinkman JA, Zwep B, Verbaten MN (1987) Dynamic vs static stimuli in their effect on visual vigilance performance. Percept Motor Skills 70:823–831

    Google Scholar 

  • Levin ED (1992) Nicotinic systems and cognitive function. Psychopharmacology 108:417–431

    Google Scholar 

  • Levin ED, Castonguay M, Ellison GD (1987) Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats. Behav Neural Biol 48:206–212

    Google Scholar 

  • Levin ED, Briggs SJ, Christopher NC, Rose JD (1992) Persistence of chronic nicotine-induced cognitive facilitation. Behav Neural Biol 58:152–158

    Google Scholar 

  • Levin ED, Briggs SJ, Christopher NC, Rose JE (1993a) Chronic nicotinic stimulation and blockade effects on working memory. Behav Pharmacol 4:179–182

    Google Scholar 

  • Levin ED, Christopher NN, Briggs SJ, Rose JE (1993b) Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalcortical projection. Cognit Brain Res 1:137–143

    Google Scholar 

  • Martin BR, Onaivi ES, Martin TJ (1989) What is the nature of mecamylamine's antagonism of the central effects of nicotine? Biochem Pharmacol 38:3391–3397

    Google Scholar 

  • McGaughy J, Sarter M (1995) Behavioral vigilance in rats: task validation, and effects of age, amphetamine, and benzodiazepine receptor ligands. Psychopharmacology, (in press)

  • Moore H, Dudchenko P, Bruno JP, Sarter M (1992) Toward modeling age-related changes of attentional abilities in rats: simple and choice reaction time tasks and vigilance. Neurobiol Aging 13:759–772

    Google Scholar 

  • Mundi WR, Iwamato ET (1988) Actions of nicotine on the acquisition of an autoshaped lever-touch response in rats. Psychopharmacology 94:267–274

    Google Scholar 

  • Muir JL, Dunnett SB, Robbins TW, Everitt BJ (1992) Attentional functions of the forebrain cholinergic systems: effects of intraventricular hemicholinium, physostigmine, basal forebrain lesions and intracortical grafts on a multiple-choice serial reaction time task. Exp Brain Res 89:611–622

    Google Scholar 

  • Muir JL, Everitt BJ, Robbins TW (1994) AMPA-induced excitotoxic lesions of the basal forebrain: a signficant role for the cortical cholinergic system in attentional function. J Neurosci 14:2313–2326

    Google Scholar 

  • Muir JL, Everitt, BJ, Robbins TW (1995) Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron. Psychopharmacology, (in press)

  • Nelsen JM, Goldstein L (1972) Improvement of performance on an attention task with chronic nicotine treatment in rats. Psychopharmacology 26:347–360

    Google Scholar 

  • Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, Murphy DL (1988) Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology 95:171–175

    Google Scholar 

  • Newhouse PA, Potter A, Corwin J, Lenox R (1992) Acute nicotinic blockade produces cognitive impairment in normal humans. Psychopharmacology 108:480–484

    Google Scholar 

  • Nordberg A, Bergh C (1985) Effect of nicotine on passive avoidance behavior and motoric activity in mice. Acta Pharmacol Toxicol 56:337–341

    Google Scholar 

  • Nordberg A, Romanelli L, Sundwall A, Bianchi C, Beani L (1989) Effect of acute and subchronic nicotine treatment on cortical acetylcholine release and on nicotinic receptors in rats and guinea pigs. Br J Pharmacol 98:71–78

    Google Scholar 

  • Parasurman R, Mouloua M (1987) Interaction between signal discriminability and task type in vigilance decrement. Percept Psychophys 41:17–22

    Google Scholar 

  • Parkinson D, Kratz KE, Daw NW (1988) Evidence for a nicotinic component to the actions of acetylcholine in cat visual cortex. Exp Brain Res 73:553–568

    Google Scholar 

  • Pritchard WS, Robinson JH, Guy TD (1992) Enhancement of continuous performance task reaction time by smoking in nondeprived smokers. Psychopharmacology 108:437–442

    Google Scholar 

  • Reavill C, Walther B, Stolerman IP Testa B (1990) Behavioural and pharmacokinetic studies on nicotine, cystine and lobeline. Neuropharmacology 29:619–624

    Google Scholar 

  • Rupniak NML, Steventon MJ, Field MJ, Jennings CA, Iversen SD (1989) Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects. Psychopharmacology 99:189–195

    Google Scholar 

  • Rusted JM, Warburton DM (1992) Facilitation of memory by posttrial administration of nicotine: evidence for an attentional explanation. Psychopharmacology 108:452–455

    Google Scholar 

  • Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br J Psychiatry 154:797–800

    Google Scholar 

  • Sahgal A (1987) Some limitations of indices derived from signal detection theory: evaluation of an alternative index for measuring bias in memory tasks. Psychopharmacology 91:517–520

    Google Scholar 

  • Sansone M, Castellano C, Battaglia M, Ammassari-Teule M (1991) Effects of oxiracetam-nicotine combinations on active and passive avoidance learning in mice. Pharmacol Biochem Behav 39:197–200

    Google Scholar 

  • Sarter M (1991) Taking stock of cognition enhancers. Trends Pharmacol Sci 12:456–461

    Google Scholar 

  • Sarter M (1994) Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin? Psychopharmacology 114:539–550

    Google Scholar 

  • Sarter M, Bruno JP (1994) Cognitive functions of cortical acetylcholine: lessons from studies on the transsynaptic modulation of activated efflux. Trends Neurosci 17:217–221

    Google Scholar 

  • Sarter M, Bruno JP, Dudchenko P (1990) Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification. Psychopharmacology 101:1–17

    Google Scholar 

  • Sarter M, Hagan J, Dudchenko P (1992a) Behavioral screening for cognition enhancers: from indiscriminate to valid testing. Part I. Psychopharmacology 107:144–159

    Google Scholar 

  • Sarter M, Hagan J, Dudchenko P (1992b) Behavioral screening for cognition enhancers: from indiscriminate to valid testing. Part II. Psychopharmacology 107:461–463

    Google Scholar 

  • Sarter M, Dudchenko P, Moore H, Holley LA, Bruno JP (1992c) Cognition enhancement based on GABA-cholinergic interactions. In: Levin ED, Decker M, Butcher LL (eds) Neurotransmitter interactions and cognitive functions. Boston, Birkhäuser, pp 329–354

    Google Scholar 

  • Schechter M, Rosecrans JA (1972) Nicotine as a discriminative cue in rats: inability of related drugs to produce a nicotine-like cueing effect. Psychopharmacology 27:379–387

    Google Scholar 

  • Terry AV, Buccafusco JJ, Jackson WJ (1993) Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys. Pharmacol Biochem Behav 45:925–929

    Google Scholar 

  • Warburton DM, Rusted JM, Fowler J (1992) A comparison of the attentional and consolidation hypotheses for the facilitation of memory by nicotine. Psychopharmacology 108:443–447

    Google Scholar 

  • Welzl H, Allessandri B, Oettinger R, Bättig K (1988) The effects of long-term nicotine treatment on locomotion, exploration and memory in young and old rats. Psychopharmacology 96:317–323

    Google Scholar 

  • Wesnes K, Warburton DM (1983) Effects of smoking on rapid information processing performance. Neuropsychobiology 9:223–229

    Google Scholar 

  • Widzowski DV, Vregan E, Bialobok P (1994) Effects of nicotinic agonists and antagonists on spatial working memory in normal adult and aged rats. Drug Dev Res 31:24–31

    Google Scholar 

  • Wonnacott S (1990) The paradox of nicotine acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11:216–219

    Google Scholar 

  • Zar JH (1974) Biostatistical analysis. Prentice Hall, N.J.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychology and Neuroscience Program, The Ohio State University, 27 Townshend Hall, 43210L, Columbus, OH, USA

    J. Turchi, L. A. Holley & M. Sarter

Authors
  1. J. Turchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. A. Holley
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Sarter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Turchi, J., Holley, L.A. & Sarter, M. Effects of nicotinic acetylcholine receptor ligands on behavioral vigilance in rats. Psychopharmacology 118, 195–205 (1995). https://doi.org/10.1007/BF02245840

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02245840

Key words

Search

Navigation